Biomedical advances have dramatically changed the landscape of HIV prevention and treatment domestically and globally. Pre-exposure prophylaxis (PrEP), vaginal microbicides, male circumcision, and antiretroviral therapy (ART) for prevention of mother-to-child transmission (PMTCT) have all been shown to reduce transmission in large trials, improve availability and access to ART and result in significant reductions in morbidity and mortality in HIV-infected infants, children and adults;Moreover, people with treatment-induced suppression of HIV viremia are less likely to infect others. As exciting as these biomedical advances are, they all depend on sustained changes in human behavior, and success of any future vaccine depends on acceptance and uptake and potentially, adherence to multiple doses over time. In 2006, the HU CFAR held a Strategic Planning Meeting in which the membership recognized the need for increased behavioral science efforts to examine how psychosocial and contextual factors influence HIV-related behaviors and to identify intervention points. This led to formation of the Behavioral and Social Sciences Program (BSSP) within the HU CFAR. As this has grown, there has been an increased need to provide behavioral/social science services to HU CFAR members and to mentor junior faculty and fellows. In addition, there has been an increasing need for integration of behavioral science into the context of HIV treatment programs and vaccine development. To this end, the Behavioral and Social Sciences Core has been established, to not just as a convener, but also provide critical services to the membership that are otherwise not available. The new Behavioral and Social Sciences Core will have the following specific aims: 1. To provide collaborative and consultation services to HU'CFAR members on behavioral and social science aspects of HIV prevention, treatment, and translational research projects. 2. To leverage infrastructure from HU CFAR biomedical projects to develop new behavioral/social science studies. 3. To foster community-based-participatory research and community engagement by providing a scientific and organizational base for HU CFAR's Community Programs.

Public Health Relevance

We propose a Behavioral and Social Sciences Core for the Harvard University Center for AIDS Research that will provide services to behavioral and biomedical researchers;will leverage ongoing biomedical projects to integrate behavioral/social science and conduct add-on behavioral/ social science studies;and will engage community stakeholders to increase buy-in of research and acceptance of new biomedical technologies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI060354-11
Application #
8697509
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
11
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Harvard Medical School
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02138
Alvi, Raza M; Neilan, Anne M; Tariq, Noor et al. (2018) Protease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart Failure. J Am Coll Cardiol 72:518-530
Rogers, Brooke G; Mendez, Noelle A; Mimiaga, Matthew J et al. (2018) ""I Wasn't in My Right Mind"": Qualitative Findings on the Impact of Alcohol on Condom Use in Patients Living with HIV/AIDS in Brazil, Thailand, and Zambia (HPTN 063). Int J Behav Med :
Looby, Sara E; Psaros, Christina; Raggio, Greer et al. (2018) Association between HIV status and psychological symptoms in perimenopausal women. Menopause 25:648-656
Bassett, Ingrid V; Xu, Ai; Govere, Sabina et al. (2018) Contraception and PrEP in South African Hair Salons: Owner, Stylist, and Client Views. J Acquir Immune Defic Syndr 79:e78-e81
Clayton, Kiera L; Collins, David R; Lengieza, Josh et al. (2018) Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system. Nat Immunol 19:475-486
Shapiro, Adrienne E; Hong, Ting; Govere, Sabina et al. (2018) C-reactive protein as a screening test for HIV-associated pulmonary tuberculosis prior to antiretroviral therapy in South Africa. AIDS 32:1811-1820
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Ojikutu, Bisola O; Srinivasan, Sumeeta; Bogart, Laura M et al. (2018) Mass incarceration and the impact of prison release on HIV diagnoses in the US South. PLoS One 13:e0198258
Bebell, Lisa M; Ngonzi, Joseph; Siedner, Mark J et al. (2018) HIV Infection and risk of postpartum infection, complications and mortality in rural Uganda. AIDS Care 30:943-953
North, Crystal M; Muyanja, Daniel; Kakuhikire, Bernard et al. (2018) Brief Report: Systemic Inflammation, Immune Activation, and Impaired Lung Function Among People Living With HIV in Rural Uganda. J Acquir Immune Defic Syndr 78:543-548

Showing the most recent 10 out of 1030 publications